Early Experience with Tarlatamab (T-Cell Engagers) for Extensive-Stage Small Cell Lung Cancer (ES-SCLC) in Canada: Lessons Learned and Implementation Strategies

As bispecific T-cell engagers (TCEs) gain traction in the oncology treatment landscape, cancer centres must develop robust clinical pathways to ensure their safe and efficient delivery. Given the limited experience of the Canadian medical oncology community with TCEs, collecting and publishing early...

Cijeli opis

Bibliografski detalji

Glavni autori:	Parneet K. Cheema, Kirstin A. Perdrizet, Randeep S. Sangha, Daniel Breadner, Nathalie Daaboul, Shannon Farley, Kevin Jao, Geoffrey Liu, Becky Logan, Barbara Melosky, Anthony Reiman, Stephanie Snow, Sunil Yadav, Shaqil Kassam
Format:	Artigo
Jezik:	Inglês
Izdano:	MDPI AG 2026-01-01
Serija:	Current Oncology
Teme:	cytokine release syndrome immune effector cell-associated neurotoxicity syndrome bispecific antibody
Online pristup:	https://www.mdpi.com/1718-7729/33/2/84
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!